Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 323.77M | 578.16M | 579.75M | 561.69M | 574.96M |
| Total Receivables | 39.22M | 28.87M | 39.26M | 39.53M | 55.71M |
| Inventory | 50.08M | 50.41M | 49.29M | 49.85M | 51.40M |
| Prepaid Expenses | 16.07M | 21.66M | 17.06M | 16.82M | 17.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 429.15M | 679.10M | 685.36M | 667.88M | 699.91M |
|
|
|||||
| Total Current Assets | 429.15M | 679.10M | 685.36M | 667.88M | 699.91M |
| Net Property, Plant & Equipment | 217.03M | 164.56M | 165.50M | 161.63M | 222.65M |
| Long-term Investments | 159.88M | 171.79M | 326.03M | 326.03M | 326.03M |
| Goodwill | 159.88M | 171.79M | 326.03M | 326.03M | 326.03M |
| Total Other Intangibles | 194.96M | 201.86M | 207.25M | 214.12M | 220.99M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.24M | 60.91M | 63.47M | 74.98M | 9.32M |
| Total Assets | 1.01B | 1.28B | 1.45B | 1.44B | 1.49B |
|
|
|||||
| Total Accounts Payable | 11.96M | 9.49M | 12.54M | 8.23M | 10.73M |
| Total Accrued Expenses | 28.02M | 26.88M | 26.32M | 22.55M | 29.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.71M | 13.47M | 13.27M | 13.08M | 12.85M |
| Total Finance Division Other Current Liabilities | 3.29M | 13.40M | 16.43M | 15.17M | 34.85M |
| Total Other Current Liabilities | 3.29M | 13.40M | 16.43M | 15.17M | 34.85M |
| Total Current Liabilities | 56.97M | 63.24M | 68.55M | 59.02M | 87.47M |
|
|
|||||
| Total Current Liabilities | 56.97M | 63.24M | 68.55M | 59.02M | 87.47M |
| Long-Term Debt | 290.49M | 516.28M | 517.08M | 517.89M | 518.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 72.49M | 83.60M | 84.85M | 87.74M | 79.41M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.09M | 1.97M | 705.00K | 2.60M | 11.98M |
| Total Liabilities | 431.04M | 665.09M | 671.19M | 667.25M | 697.57M |
|
|
|||||
| Common Stock & APIC | 184.40M | 178.10M | 170.86M | 137.00M | 131.02M |
| Retained Earnings | 140.89M | 167.04M | 266.07M | 273.66M | 285.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 325.29M | 345.14M | 436.93M | 410.66M | 416.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 325.29M | 345.14M | 436.93M | 410.66M | 416.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 251.92M | 267.99M | 339.48M | 366.73M | 373.13M |
| Total Equity | 577.21M | 613.13M | 776.41M | 777.39M | 789.88M |
|
|
|||||